nifedipine has been researched along with labetalol in 134 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (19.40) | 18.7374 |
| 1990's | 14 (10.45) | 18.2507 |
| 2000's | 19 (14.18) | 29.6817 |
| 2010's | 49 (36.57) | 24.3611 |
| 2020's | 26 (19.40) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Buckley, DB; Funk, RS; Hensley, T; Kazmi, F; Loewen, GJ; Parkinson, A; Pope, C | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Andréjak, M; Bataille, P; Fournier, A; Gheerbrant, JD; Hardin, JM; Makdassi, R | 1 |
| Fransson, L; Koch, G | 2 |
| Bunchman, TE; Lynch, RE; Wood, EG | 1 |
| Fairlie, FM | 1 |
| d'Allens, H; Decoulx, M; Godon, P; Pappo, M | 1 |
| Prasad, NK | 1 |
| Gonzalez, DG; Ram, CV | 1 |
| Calder, AA; Forbes, CD; Greer, IA; Walker, JJ | 1 |
| Littler, WA; Smith, SA | 1 |
| Naden, RP; Redman, CW | 1 |
| Koch, G | 1 |
| Hussain, M; Nelson, GI; Reynolds, GW; Richmond, A; Silke, B; Taylor, SH; Verma, SP; Wilson, JA | 1 |
| Hashimoto, T; Kaguchi, Y; Kimura, M; Kuriyama, S; Miyahara, T; Nakamura, K; Tamai, K; Tamura, H | 1 |
| Crake, T; Fox, K; Mulcahy, D; Wright, C | 1 |
| Cubeddu, LX; Halperin, AK | 1 |
| Catapano, MS; Marx, JA | 1 |
| Meese, RB; Ram, CV | 1 |
| Karlberg, BE; Ohman, KP; von Schenck, H; Weiner, L | 1 |
| Casthely, PA; Fyman, PN; Gandhi, P; Litwak, B; Rabinowitz, L; Villanueva, R | 1 |
| Oh, VM | 1 |
| Anand, MP | 1 |
| Lowenthal, DT | 1 |
| Rahn, KH | 1 |
| Ram, CV | 1 |
| Song, YC | 1 |
| Albanesi Filho, FM; Barbosa, ET; Batlouni, M; Benchimol, AB; Benchimol, CB; da Cunha, GP; Duprat, R; Maciel, R; Maranhão, MF; Pillegi, F; Saad, EA; Sbissa, AS; Schlesinger, P | 1 |
| Bar-Andziak, E; Chlewicka, I | 1 |
| Lee, J; Lubbe, WF; Opie, LH; White, D | 1 |
| Stoudemire, A | 1 |
| Connelly, JF | 1 |
| Figiel, GS; LaPlante, R; McDonald, L | 1 |
| Gales, MA | 1 |
| Breckenridge, A; Mackay, E; Scott, A; Tsao, Y; Vandenburg, M; Walley, T | 1 |
| Jacobson, S; McDonald, AJ; Yealy, DM | 1 |
| Bruschettini, PL; Gazzolo, D; Russo, A; Santi, F; Scopesi, F; Visser, GH | 1 |
| Chauhan, SP; Newman, RB; Scardo, JA; Vermillion, ST | 1 |
| Chauhan, SP; Hogg, BB; Newman, RB; Scardo, JA; Vermillion, ST | 1 |
| Brilla, CG | 1 |
| Marik, PE; Varon, J | 1 |
| Ameriso, S; Fischberg, GM; Fisher, MJ; Lozano, E; Rajamani, K | 1 |
| Hussein, M; Mooij, JM; Roujouleh, H | 1 |
| Bhargava, KK; Gupta, S; Ito, Y; McCuskey, RS; Palestro, CJ; Rajvanshi, P; Slehria, S; Sokhi, RP | 1 |
| Hoffman, RS; Howland, MA; Nelson, LS; Schier, JG | 1 |
| Dennedy, MC; Houlihan, DD; Morrison, JJ; Ravikumar, N | 1 |
| Ayazifar, M; Murphy, MA | 1 |
| Heazell, AE; Mahomoud, S; Pirie, AM | 1 |
| Weber, MA | 1 |
| Frishman, WH; Schlocker, SJ; Tejani, N; Veresh, M | 1 |
| Cleper, R; Davidovits, M; Kovalski, Y; Krause, I; Sinai, L | 1 |
| Wu, D; Yee, LM | 1 |
| Beutler, JJ; de Gooijer, A; Gaillard, CA; Kroon, AA; van den Born, BJ; van den Meiracker, AH | 1 |
| Omar, SZ; Raheem, IA; Saaid, R; Tan, PC | 1 |
| Battistoni, GI; Bezzeccheri, V; Cecchi, L; Cecchi, S; Giannubilo, SR; Landi, B; Tranquilli, AL; Vitali, P | 1 |
| Ong, CT; Sung, SF; Tong, SH; Wu, CS | 1 |
| Gong, SP; Huang, LP; Liu, QQ; Yu, YH | 1 |
| Bos, AF; Kooi, EM; van den Berg, PP; Verhagen, EA | 1 |
| Alexander, JM; Wilson, KL | 1 |
| Arulkumaran, N; Lightstone, L | 1 |
| Sharma, C; Shekhar, S; Thakur, S; Verma, S | 1 |
| Firoz, T; Gordon, R; MacDonell, K; Magee, LA; Payne, BA; Vidler, M; von Dadelszen, P | 1 |
| Simon, M; Vadhera, RB | 1 |
| Leng, W; Mi, C; Shi, Q; Xing, A; Yao, Q | 1 |
| Gupta, N; Kirubakaran, R; Pareek, P; Shekhar, S | 1 |
| Magee, LA | 1 |
| Clark, SM; Dunn, HE; Hankins, GD | 1 |
| Olson-Chen, C; Seligman, NS | 1 |
| Abreo, A; Greene, N; Kilpatrick, SJ; Main, EK; Melsop, K; Peterson, N; Shields, LE | 1 |
| Bos, AF; Kooi, EM; Richter, AE; Schat, TE; Scherjon, SA; Van Braeckel, KN | 1 |
| Shi, DD; Wang, N; Yang, FZ; Zhou, L | 1 |
| Greene, N; Kilpatrick, SJ; Sharma, KJ | 1 |
| Kilpatrick, SJ; Sharma, KJ | 1 |
| Chamley, LW; Chen, Q; Stone, PR; Tong, M; Wise, MR; Xiao, F; Xiao, X; Zhao, M | 1 |
| Arjona-Berral, JE; Castelo-Branco, C; Duro-Gómez, J; Duro-Gómez, L; Giménez de Azcárete, M; Hernández-Angeles, C; Rodríguez-Marín, AB | 1 |
| Chen, L; Shi, D; Wang, Y | 1 |
| Chappell, LC; Cruickshank, JK; Khalil, A; Mills, C; Myers, JE; Nelson-Piercy, C; Seed, PT; Watt-Coote, I; Webster, LM | 1 |
| Chappell, L; Chmiel, C; Johnstone, ED; Mistry, H; Myers, JE; Shawkat, E; Webster, L | 1 |
| Broscious, R; Devabhakthuni, S; Noel, ZR; Watson, K | 1 |
| Sequeira, RP; Sridharan, K | 1 |
| Gainder, S; Prakash, M; Saha, SC; Thakur, M | 2 |
| Sowjanya, R; Tatapudi, R; Zulfeen, M | 1 |
| Jim, B; Reddy, S | 1 |
| Chen, PC; Hsu, CY; Huang, LY; Lee, JD; Lee, M; Ovbiagele, B; Saver, JL; Wu, YL | 1 |
| Bracken, H; Easterling, T; Magee, LA; Mool, S; Mundle, S; Parvekar, S; Shochet, T; von Dadelszen, P; Winikoff, B | 1 |
| Karumanchi, SA; Lemoine, ER | 1 |
| Burns, A; Chappell, LC; Gupta, P; Myers, JE; Nelson-Piercy, C; Patel, P; Reed, K; Seed, PT; Webster, LM; Wiesender, C | 1 |
| Akerman, MB; Elsayad, A; Halpern, TA; Heiselman, CJ; Heo, HJ; Kantorowska, A; Muscat, JC; Sicuranza, GB; Vintzileos, AM | 1 |
| Wang, DJ; Wu, Y; Zhang, R; Zhang, Y; Zhang, YX | 1 |
| Belfort, MA; Clark, SL; Fox, KA; Sangi-Haghpeykar, H; Tolcher, MC | 1 |
| Doherty, A; Kingdom, JC; McLaughlin, K | 1 |
| Balli, K; Figueroa, H; Johns, K; Martin, C; Pappas, J; Yao, R | 1 |
| Alers, RJ; Cauffman, E; Ghossein-Doha, C; Lopes van Balen, VA; Mulder, EG; Oben, J; Schiffer, VMMM; Smits, L; Spaanderman, MEA; van Kuijk, SMJ | 1 |
| Daubert, MA; Fashe, MM; Garcia, JE; Lee, CR; Loop, MS; Mulrenin, IR; Urrutia, RP | 1 |
| Ashworth, D; Battersby, C; Chappell, LC; Cluver, C; Green, M; Hardy, P; McManus, RJ | 1 |
| Antony, KM; Bastian, IN | 1 |
| Cheng, Y; Jiang, YF; Li, JB; Wu, HZ; Yu, D; Zhu, ZN | 1 |
| Avalos, LA; Badon, SE; Bider-Canfield, Z; Cheetham, TC; Chen, L; Dublin, S; Easterling, TR; Holt, VL; Idu, A; Nance, N; Neugebauer, RS; Reynolds, K; Shortreed, SM | 1 |
| Greene, NH; Kilpatrick, SJ; Pon, FF | 1 |
| Do, SC; Druzin, ML; El-Sayed, YY; Girsen, AI; Herrero, T; Kan, P; Leonard, SA; Lyell, DJ; Panelli, DM | 1 |
| Allegaert, K; Flint, RB; Mian, P; Schoenmakers, S; van de Vusse, D; Versmissen, J; Visser, W | 1 |
| Hoffman, MC; Wautlet, CK | 1 |
| Gu, S; Shao, Y; Zhang, X | 1 |
| Daly, PL; Goodwin, ET; Kipnis, CM; Smith, DK | 1 |
| Connealy, B; D Dahlke, J; Lovgren, T; Yao, R | 1 |
| Al-Shehab, U; Lo, DF; Wasif, U | 1 |
| Lovgren, T | 1 |
| Hamidy, Y; Novri, DA; S, D; Savira, M | 1 |
| Cui, S; Ou, M; Yu, Y; Zhang, F; Zhao, S | 1 |
| Bajpai, D; Dumanski, S; Popa, C; Shah, S; Verma, P | 1 |
| Ashworth, D; Battersby, C; Bick, D; Chappell, LC; Green, M; Hardy, P; Leighton, L; Magee, LA; Maher, A; McManus, RJ; Moakes, C; Morris, RK; Myers, J; Nelson-Piercy, C; Rivero-Arias, O; Sparkes, J; Webb, A; Wilson, H | 1 |
| Dong, W; Peng, Z; Xiao, Y; Zhang, J | 1 |
34 review(s) available for nifedipine and labetalol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Doppler flow velocimetry in hypertension in pregnancy.
Topics: Female; Fetus; Hemodynamics; Humans; Hypertension; Labetalol; Mass Screening; Nifedipine; Placenta; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Ultrasonography, Prenatal | 1991 |
Antihypertensive agents--the race for third place.
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Diazoxide; Felodipine; Humans; Hydralazine; Indoramin; Labetalol; Minoxidil; Nicardipine; Nifedipine; Vasodilator Agents; Verapamil | 1985 |
Antihypertensive drugs in pregnancy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Diazoxide; Diuretics; Female; Fetus; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Nifedipine; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Regional Blood Flow; Uterus | 1985 |
The role of calcium channel blockers in the treatment of hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Follow-Up Studies; Heart Rate; Hemodynamics; Humans; Hypertension; Kidney; Kinetics; Labetalol; Nifedipine; Sympathetic Nervous System; Verapamil | 1986 |
Hypertensive cardiovascular emergencies.
Topics: Antihypertensive Agents; Brain Diseases; Cerebrovascular Disorders; Clonidine; Coronary Disease; Diazoxide; Diuretics; Eclampsia; Emergencies; Female; Humans; Hypertension; Hypertension, Malignant; Labetalol; Minoxidil; Nifedipine; Nitroprusside; Pregnancy; Pulmonary Edema; Trimethaphan | 1985 |
Clinical pharmacology of beta-adrenoceptor antagonism in angina pectoris: an overview.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Airway Obstruction; Angina Pectoris; Anti-Arrhythmia Agents; Drug Therapy, Combination; Humans; Labetalol; Nifedipine; Vasodilator Agents | 1980 |
Hypertension--drug management.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Calcium Channel Blockers; Captopril; Diazoxide; Humans; Hypertension; Indoramin; Labetalol; Minoxidil; Nifedipine; Nitroprusside; Prazosin; Sympatholytics; Vasodilator Agents; Verapamil | 1982 |
Hypertensive crisis.
Topics: Antihypertensive Agents; Brain Diseases; Cerebrovascular Disorders; Clonidine; Coronary Disease; Diazoxide; Eclampsia; Emergencies; Female; Humans; Hydralazine; Hypertension; Hypertension, Malignant; Labetalol; Minoxidil; Nifedipine; Nitroprusside; Phentolamine; Prazosin; Pregnancy; Pulmonary Edema; Trimethaphan | 1984 |
Antihypertensive drugs of choice for treating preeclampsia.
Topics: Antihypertensive Agents; Female; Fetal Distress; Humans; Labetalol; Nifedipine; Pre-Eclampsia; Pregnancy | 1994 |
Oral antihypertensives for hypertensive urgencies.
Topics: Administration, Oral; Antihypertensive Agents; Blood Pressure; Captopril; Clonidine; Female; Humans; Hypertension; Labetalol; Male; Nifedipine; Randomized Controlled Trials as Topic | 1994 |
The diagnosis and management of hypertensive crises.
Topics: Antihypertensive Agents; Aortic Aneurysm; Aortic Dissection; Clonidine; Diazoxide; Enalaprilat; Female; Fenoldopam; Humans; Hypertension; Labetalol; Nicardipine; Nifedipine; Nitroprusside; Phentolamine; Pre-Eclampsia; Pregnancy; Propanolamines; Trimethaphan | 2000 |
The role of the new beta-blockers in treating cardiovascular disease.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Benzopyrans; Cardiovascular Diseases; Clinical Trials as Topic; Enalapril; Ethanolamines; Female; Heart Failure; Hemodynamics; Humans; Hypertension; Labetalol; Losartan; Male; Metoprolol; Middle Aged; Nebivolol; Nifedipine; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Sympathomimetics | 2005 |
Pathophysiology and medical management of systemic hypertension in preeclampsia.
Topics: Adrenergic beta-Antagonists; Aspirin; Calcium; Calcium Channel Blockers; Cerebral Hemorrhage; Female; Glomerular Filtration Rate; Humans; Hypertension; Ischemia; Labetalol; Liver; Nicardipine; Nifedipine; Placenta; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Prostaglandins; Stroke | 2006 |
[Clinical efficacy and perinatal outcome of nifedipine for severe preeclampsia: meta-analysis].
Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension; Infant, Newborn; Labetalol; Nifedipine; Perinatal Mortality; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Respiratory Distress Syndrome, Newborn; Severity of Illness Index | 2012 |
Hypertensive emergencies of pregnancy.
Topics: Antihypertensive Agents; Calcium Channel Blockers; Creatine; Diuretics; Emergency Medicine; Female; Fetal Monitoring; Humans; Hydralazine; Infusions, Intravenous; Labetalol; Methyldopa; Nifedipine; Nitroprusside; North America; Oliguria; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Proteinuria | 2013 |
Severe pre-eclampsia and hypertensive crises.
Topics: Administration, Intravenous; Administration, Oral; Antihypertensive Agents; Critical Care; Early Diagnosis; Eclampsia; Female; HELLP Syndrome; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Labetalol; Magnesium Sulfate; Methyldopa; Nifedipine; Nitroglycerin; Pre-Eclampsia; Pregnancy; Risk Assessment; Risk Factors; Severity of Illness Index; Treatment Outcome; United Kingdom | 2013 |
Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review.
Topics: Administration, Oral; Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Labetalol; Methyldopa; Nifedipine; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Randomized Controlled Trials as Topic; Treatment Outcome; Vasodilator Agents | 2014 |
Hypertensive emergencies in pregnancy.
Topics: Antihypertensive Agents; Eclampsia; Emergencies; Female; Humans; Hydralazine; Hypertension; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Severity of Illness Index | 2014 |
Oral nifedipine versus intravenous labetalol for the treatment of severe hypertension in pregnancy.
Topics: Administration, Oral; Antihypertensive Agents; Female; Humans; Hypertension; Infusions, Intravenous; Labetalol; Nifedipine; Pregnancy; Pregnancy Complications, Cardiovascular; Severity of Illness Index; Treatment Outcome | 2015 |
Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis.
Topics: Administration, Intravenous; Administration, Oral; Adult; Antihypertensive Agents; Cost-Benefit Analysis; Evidence-Based Medicine; Female; Humans; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications, Cardiovascular; Treatment Outcome | 2016 |
A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Pregnancy; Pregnancy Complications, Cardiovascular; Treatment Outcome; Vasodilator Agents | 2015 |
Hypertensive Emergencies in Pregnancy.
Topics: Antihypertensive Agents; Cesarean Section; Chronic Disease; Congenital Abnormalities; Emergencies; Esophageal Atresia; Female; Heart Defects, Congenital; Humans; Hydralazine; Hypertension; Hypertension, Pregnancy-Induced; Hypospadias; Labetalol; Labor, Induced; Male; Nifedipine; Postnatal Care; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Prevalence; United States | 2016 |
Postpartum Hypertension: Etiology, Diagnosis, and Management.
Topics: Antihypertensive Agents; Blood Pressure; Disease Management; Female; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Postpartum Period; Pregnancy; Puerperal Disorders | 2017 |
Focused Update on Pharmacologic Management of Hypertensive Emergencies.
Topics: Administration, Oral; Antihypertensive Agents; Blood Pressure; Brain Ischemia; Emergencies; Enalaprilat; Female; Guideline Adherence; Heart Failure; Humans; Hydralazine; Hypertension; Infusions, Intravenous; Intracranial Hemorrhages; Labetalol; Nifedipine; Pre-Eclampsia; Pregnancy; Pyridines; Stroke | 2018 |
Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials.
Topics: Antihypertensive Agents; Dose-Response Relationship, Drug; Female; Headache; Humans; Hydralazine; Hypertension; Hypotension; Incidence; Labetalol; Network Meta-Analysis; Nifedipine; Perinatal Death; Pregnancy; Pregnancy Complications, Cardiovascular; Randomized Controlled Trials as Topic; Stillbirth; Tachycardia; Treatment Outcome | 2018 |
Hypertension and Pregnancy: Management and Future Risks.
Topics: Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Chronic Disease; Diuretics; Female; Humans; Hypertension; Hypertension, Pregnancy-Induced; Labetalol; Methyldopa; Nifedipine; Platelet Aggregation Inhibitors; Pre-Eclampsia; Preconception Care; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Care; Renal Insufficiency, Chronic; Risk Factors; Vasodilator Agents | 2019 |
Hemodynamic Complications in Pregnancy: Preeclampsia and Beyond.
Topics: Anticonvulsants; Antihypertensive Agents; Aspirin; Delivery, Obstetric; Female; Fetal Growth Retardation; Hemodynamics; Humans; Labetalol; Magnesium Sulfate; Nifedipine; Placentation; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Risk Assessment | 2020 |
The Impact of Pregnancy on Antihypertensive Drug Metabolism and Pharmacokinetics: Current Status and Future Directions.
Topics: Antihypertensive Agents; Female; Humans; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Pharmaceutical Preparations; Pregnancy | 2021 |
Different dosage regimens of nifedipine, labetalol, and hydralazine for the treatment of severe hypertension during pregnancy: a network meta-analysis of randomized controlled trials.
Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension; Hypertension, Pregnancy-Induced; Infant, Newborn; Labetalol; Network Meta-Analysis; Nifedipine; Pregnancy; Randomized Controlled Trials as Topic | 2022 |
Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review.
Topics: Antihypertensive Agents; Female; Humans; Hypertension; Hypertension, Pregnancy-Induced; Labetalol; Methyldopa; Nifedipine; Pregnancy; Pregnancy Complications, Cardiovascular | 2022 |
Hypertensive Crisis in Pregnancy.
Topics: Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension; Labetalol; Nifedipine; Pregnancy | 2022 |
Oral nifedipine may be a preferential option for treating acute severe hypertension during pregnancy: a meta-analysis.
Topics: Blood Pressure; Female; Humans; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Pregnancy | 2023 |
Evaluation and Management of Hypertensive Disorders of Pregnancy.
Topics: Antihypertensive Agents; Female; Humans; Hypertension, Pregnancy-Induced; Infant, Newborn; Labetalol; Nifedipine; Pre-Eclampsia; Pregnancy | 2023 |
28 trial(s) available for nifedipine and labetalol
| Article | Year |
|---|---|
[Hypertension in the elderly. Comparison of the efficacy and tolerability of labetalol and nifedipine. A multicenter, randomized, single-blind study].
Topics: Aged; Aged, 80 and over; Humans; Hypertension; Labetalol; Multicenter Studies as Topic; Nifedipine; Randomized Controlled Trials as Topic; Single-Blind Method | 1990 |
Labetalol and nifedipine in the management of essential hypertension.
Topics: Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Nifedipine | 1990 |
Hemodynamic and adrenergic effects of combined alpha/beta-receptor blockade versus combined beta-receptor and slow channel calcium blockade in patients with ischemic heart disease.
Topics: Adult; Aged; Blood Pressure; Coronary Disease; Drug Therapy, Combination; Exercise Test; Hemodynamics; Humans; Labetalol; Male; Metoprolol; Middle Aged; Nifedipine; Random Allocation | 1989 |
Differential hemodynamic effects of beta-adrenoceptor blockers, Ca antagonists and combined alpha-beta-receptor blockade in ischemic heart disease.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Coronary Disease; Hemodynamics; Humans; Labetalol; Metoprolol; Middle Aged; Nifedipine; Vascular Resistance | 1986 |
Sympathetic (alpha-beta) or calcium channel blockade for hypertensive myocardial infarction? A haemodynamic comparison of labetalol and nifedipine.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Calcium Channel Blockers; Hemodynamics; Humans; Hypertension; Labetalol; Male; Middle Aged; Myocardial Infarction; Nifedipine | 1988 |
Labetalol in the treatment of stable exertional angina pectoris: a comparison with nifedipine.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Humans; Labetalol; Male; Middle Aged; Nifedipine; Random Allocation; Time Factors | 1988 |
The role of calcium channel blockers in the treatment of hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Follow-Up Studies; Heart Rate; Hemodynamics; Humans; Hypertension; Kidney; Kinetics; Labetalol; Nifedipine; Sympathetic Nervous System; Verapamil | 1986 |
Antihypertensive and metabolic effects of nifedipine and labetalol alone and in combination in primary hypertension.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Labetalol; Lipids; Male; Middle Aged; Nifedipine; Random Allocation; Renin; Renin-Angiotensin System | 1985 |
[Labetalol in the treatment of arterial hypertension. A Brazilian multicenter study].
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Nifedipine | 1982 |
Effects of dilevalol (R,R-labetalol) compared with nifedipine on heart rate, blood pressure and muscle blood flow at rest and on exercise in hypertensive patients.
Topics: Adolescent; Adult; Aged; Blood Pressure; Double-Blind Method; Exercise; Heart Rate; Humans; Hypertension; Labetalol; Leg; Middle Aged; Muscles; Nifedipine; Regional Blood Flow; Rest | 1993 |
Oral labetalol versus oral nifedipine in hypertensive urgencies in the ED.
Topics: Administration, Oral; Blood Pressure; Clinical Protocols; Diastole; Drug Administration Schedule; Emergencies; Emergency Service, Hospital; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Nifedipine; Prospective Studies; Systole; Time Factors | 1993 |
A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Emergencies; Female; Gestational Age; Humans; Hypertension; Infusions, Intravenous; Labetalol; Nifedipine; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular | 1999 |
A randomized, double-blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Electric Impedance; Emergencies; Female; Gestational Age; Heart Rate; Hemodynamics; Humans; Hypertension; Labetalol; Nifedipine; Pre-Eclampsia; Pregnancy; Vascular Resistance | 1999 |
Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Emergencies; Female; Heart Rate; Heart Rate, Fetal; Humans; Hypertension, Pregnancy-Induced; Infusions, Intravenous; Labetalol; Nifedipine; Pregnancy; Pregnancy Outcome; Prenatal Care; Treatment Outcome | 2012 |
Oral nifedipine or intravenous labetalol for hypertensive emergency in pregnancy: a randomized controlled trial.
Topics: Administration, Intravenous; Administration, Oral; Adult; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension, Pregnancy-Induced; India; Labetalol; Nifedipine; Pregnancy; Time Factors; Treatment Outcome; Vasodilator Agents; Young Adult | 2013 |
Oral nifedipine vs. intravenous labetalol for treatment of pregnancy-induced severe pre-eclampsia.
Topics: Administration, Intravenous; Administration, Oral; Adult; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Labetalol; Nifedipine; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Young Adult | 2016 |
Oral labetalol compared to oral nifedipine for postpartum hypertension: A randomized controlled trial.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Labetalol; Nifedipine; Postpartum Period; Puerperal Disorders; Treatment Outcome | 2017 |
Lipid profile and cytokines in hypertension of pregnancy: A comparison of preeclampsia therapies.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Cytokines; Double-Blind Method; Drug Administration Routes; Female; Humans; Hypertension, Pregnancy-Induced; Labetalol; Lipids; Nifedipine; Pre-Eclampsia; Pregnancy; Severity of Illness Index; Treatment Outcome | 2018 |
Longitudinal changes in vascular function parameters in pregnant women with chronic hypertension and association with adverse outcome: a cohort study.
Topics: Adult; Antihypertensive Agents; Birth Weight; Black People; Blood Pressure; Chronic Disease; Cohort Studies; Feasibility Studies; Female; Gestational Age; Humans; Hypertension; Infant, Newborn; Infant, Small for Gestational Age; Labetalol; Longitudinal Studies; Nifedipine; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Pulse Wave Analysis; Regression Analysis; Treatment Outcome | 2019 |
To study the changes in fetal hemodynamics with intravenous labetalol or nifedipine in acute severe hypertension.
Topics: Administration, Intravenous; Administration, Oral; Adult; Antihypertensive Agents; Blood Pressure; Female; Gestational Age; Heart Rate, Fetal; Humans; Labetalol; Middle Cerebral Artery; Nifedipine; Pre-Eclampsia; Pregnancy; Ultrasonography, Doppler, Color; Ultrasonography, Prenatal; Umbilical Arteries; Young Adult | 2019 |
IV labetalol and oral nifedipine in acute control of severe hypertension in pregnancy-A randomized controlled trial.
Topics: Administration, Intravenous; Administration, Oral; Antihypertensive Agents; Double-Blind Method; Female; Humans; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Pregnancy; Prospective Studies; Young Adult | 2019 |
Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension, Pregnancy-Induced; India; Infant, Newborn; Labetalol; Methyldopa; Nifedipine; Pregnancy; Pregnancy Outcome; Treatment Outcome; Young Adult | 2019 |
Quantifying adherence to antihypertensive medication for chronic hypertension during pregnancy.
Topics: Adult; Antihypertensive Agents; Blood Pressure Determination; Chromatography, High Pressure Liquid; Cohort Studies; Female; Humans; Hypertension; Labetalol; Medication Adherence; Nifedipine; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Care; Treatment Outcome | 2019 |
Intravenous labetalol versus oral nifedipine for acute hypertension in pregnancy: effects on cerebral perfusion pressure.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Cerebrovascular Circulation; Cohort Studies; Female; Humans; Hypertension, Pregnancy-Induced; Infusions, Intravenous; Labetalol; Nifedipine; Pregnancy; Prenatal Care; Prospective Studies; Ultrasonography, Doppler, Transcranial | 2020 |
To study the changes in maternal hemodynamics with intravenous labetalol or nifedipine in acute severe hypertension.
Topics: Administration, Intravenous; Administration, Oral; Adult; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Placenta; Pregnancy; Pulsatile Flow; Renal Artery; Ultrasonography, Doppler, Color; Uterine Artery | 2020 |
Effects of Nifedipine and Labetalol Combined with Magnesium Sulfate on Blood Pressure Control, Blood Coagulation Function, and Maternal and Infant Outcome in Patients with Pregnancy-Induced Hypertension.
Topics: Antihypertensive Agents; Blood Coagulation; Blood Pressure; Female; Humans; Hypertension; Hypertension, Pregnancy-Induced; Labetalol; Magnesium Sulfate; Nifedipine; Placenta; Pregnancy | 2022 |
Effectiveness of nifedipine, labetalol, and hydralazine as emergency antihypertension in severe preeclampsia: a randomized control trial.
Topics: Antihypertensive Agents; Female; Humans; Hydralazine; Labetalol; Nifedipine; Pre-Eclampsia; Pregnancy | 2022 |
A treatment strategy with nifedipine versus labetalol for women with pregnancy hypertension: study protocol for a randomised controlled trial (Giant PANDA).
Topics: Animals; Antihypertensive Agents; Female; Humans; Hypertension; Infant; Infant, Newborn; Labetalol; Multicenter Studies as Topic; Nifedipine; Pre-Eclampsia; Pregnancy; Randomized Controlled Trials as Topic; Ursidae | 2023 |
73 other study(ies) available for nifedipine and labetalol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells).
Topics: Adrenergic beta-Antagonists; Amines; Ammonium Chloride; Antidepressive Agents, Tricyclic; Atorvastatin; Cell Line, Transformed; Diuretics; Hepatocytes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imipramine; Lysosomes; Monensin; Nigericin; Propranolol; Pyrroles | 2013 |
[Clinical pharacology of the new antihypertensive drugs: renin-angiotensin system antagonists, recent vasodilators and dopaminergic agonists].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Dopamine Antagonists; Humans; Labetalol; Minoxidil; Nifedipine; Prazosin; Renin; Saralasin; Tetrahydronaphthalenes; Vasodilator Agents | 1979 |
Acute effects of combined alpha/beta-adrenoceptor blockade v combined beta-receptor and slow channel calcium blockade in ischemic heart disease complicated by hypertension. Hemodynamic and adrenergic responses.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Calcium Channel Blockers; Cardiac Output; Coronary Disease; Epinephrine; Heart Rate; Hemodynamics; Humans; Hypertension; Labetalol; Male; Metoprolol; Middle Aged; Nifedipine; Renin; Stroke Volume; Vascular Resistance | 1991 |
Intravenously administered labetalol for treatment of hypertension in children.
Topics: Adolescent; Child; Child, Preschool; Creatinine; Diazoxide; Heart Rate; Humans; Hydralazine; Hypertension; Infusions, Intravenous; Labetalol; Nifedipine; Nitroprusside; Potassium; Time Factors | 1992 |
New approaches for the treatment of hypertensive urgencies and emergencies.
Topics: Antihypertensive Agents; Captopril; Emergencies; Enalapril; Humans; Hypertension; Labetalol; Nifedipine | 1988 |
Aspirin with an adrenergic or a calcium-channel-blocking agent as new combination therapy for arterial thrombosis.
Topics: Aspirin; Drug Synergism; Ethanolamines; Humans; Labetalol; Nicardipine; Nifedipine; Platelet Aggregation; Thrombosis | 1985 |
The effects of vasoactive agents on the proliferation of vascular smooth muscle cells grown in vitro.
Topics: Amiloride; Animals; Captopril; Cell Division; Cells, Cultured; Chlorpromazine; In Vitro Techniques; Labetalol; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Nifedipine; Norepinephrine; Propranolol; Quinazolines; Rats; Sulfonamides | 1988 |
[Nifedipine, captopril and labetalol--overviews on the pattern of adverse effects].
Topics: Captopril; Cardiovascular Diseases; Drug Eruptions; Ethanolamines; Gastrointestinal Diseases; Humans; Labetalol; Nervous System Diseases; Nifedipine; Proline | 1985 |
Management of urgent hypertension: a comparison of oral treatment regimens in the emergency department.
Topics: Administration, Oral; Antihypertensive Agents; Captopril; Clonidine; Drug Administration Schedule; Emergency Service, Hospital; Hemodynamics; Humans; Hypertension; Labetalol; Minoxidil; Nifedipine; Prazosin | 1986 |
Drugs for hypertensive emergencies.
Topics: Administration, Oral; Captopril; Clonidine; Diazoxide; Emergencies; Humans; Hydralazine; Hypertension; Infusions, Parenteral; Labetalol; Nifedipine; Nitroprusside; Trimethaphan | 1985 |
Intrapulmonary shunting during deliberate hypotension with nifedipine, diltiazem and labetalol in dogs.
Topics: Anesthesia; Animals; Benzazepines; Blood Pressure; Diltiazem; Dogs; Ethanolamines; Heart Rate; Hypotension, Controlled; Labetalol; Nifedipine; Pulmonary Circulation | 1985 |
New drugs for hypertension.
Topics: Antihypertensive Agents; Bumetanide; Diltiazem; Dipeptides; Enalapril; Guanabenz; Guanidines; Humans; Indapamide; Labetalol; Nifedipine; Pindolol; Verapamil | 1984 |
[Clinical pharmacology of the newer antihypertensive agents].
Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Captopril; Guanfacine; Guanidines; Humans; Hypertension; Labetalol; Minoxidil; Nifedipine; Phenylacetates | 1983 |
[Clinical use of new antihypertensives].
Topics: Alkaloids; Antihypertensive Agents; Benzylisoquinolines; Captopril; Diazoxide; Diterpenes; Humans; Hypertension; Labetalol; Minoxidil; Nifedipine; Nitroprusside; Prazosin | 1984 |
[New hypotensive drugs].
Topics: Antihypertensive Agents; Captopril; Drug Evaluation; Guanfacine; Guanidines; Humans; Hypertension; Labetalol; Minoxidil; Nifedipine; Phenylacetates; Saralasin; Verapamil | 1981 |
Alternatives to beta-blockade in therapy of hypertension with angina pectoris: role of nifedipine or of labetalol.
Topics: Angina Pectoris; Blood Pressure; Drug Therapy, Combination; Ethanolamines; Exercise Test; Hemodynamics; Humans; Hypertension; Labetalol; Nifedipine; Pyridines | 1982 |
Cardiovascular morbidity and ECT.
Topics: Arrhythmias, Cardiac; Cardiovascular Diseases; Comorbidity; Depressive Disorder; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Hypertension; Labetalol; Middle Aged; Nifedipine | 1995 |
Cardiovascular complications of ECT.
Topics: Age Factors; Aged; Cardiovascular Diseases; Delirium; Depressive Disorder; Electroconvulsive Therapy; Humans; Labetalol; Nifedipine; Premedication | 1994 |
Pregnancy-induced hypertension, antihypertensive drugs and the development of fetal behavioural states.
Topics: Antihypertensive Agents; Cohort Studies; Embryo, Mammalian; Embryonic and Fetal Development; Female; Humans; Hypertension; Labetalol; Male; Nifedipine; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Reference Values; Ultrasonography, Prenatal | 1998 |
Regression of myocardial fibrosis in hypertensive heart disease: diverse effects of various antihypertensive drugs.
Topics: Animals; Antihypertensive Agents; Captopril; Collagen; Fibrosis; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Labetalol; Male; Myocardium; Nifedipine; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric | 2000 |
Stroke precipitated by moderate blood pressure reduction.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Emergency Treatment; Felodipine; Female; Humans; Hypertension; Labetalol; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Middle Aged; Nifedipine; Patient Selection; Precipitating Factors; Stroke; Tomography, X-Ray Computed | 2000 |
Factor analysis, including antihypertensive medication, of the outcome of pregnancy in pregnancy-associated hypertension.
Topics: Antihypertensive Agents; Apgar Score; Cesarean Section; Comorbidity; Disease Susceptibility; Female; Fetal Death; Humans; Hydralazine; Hypertension; Infant, Newborn; Labetalol; Multivariate Analysis; Nifedipine; Parity; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy in Diabetics; Pregnancy Outcome; Retrospective Studies; Risk Factors | 2001 |
Hepatic sinusoidal vasodilators improve transplanted cell engraftment and ameliorate microcirculatory perturbations in the liver.
Topics: Adrenergic alpha-Antagonists; Animals; Calcitonin Gene-Related Peptide; Calcium Channel Blockers; Dipeptidyl Peptidase 4; Glucagon; Hepatocytes; Labetalol; Liver; Liver Circulation; Microcirculation; Nifedipine; Nitroglycerin; Phentolamine; Rats; Rats, Inbred F344; Rats, Mutant Strains; Splanchnic Circulation; Vasodilator Agents | 2002 |
Fatality from administration of labetalol and crushed extended-release nifedipine.
Topics: Administration, Intranasal; Adult; Biological Availability; Cause of Death; Delayed-Action Preparations; Drug Synergism; Drug Therapy, Combination; Female; Humans; Italy; Labetalol; Nifedipine | 2003 |
Anti-hypertensive therapy and the feto-placental circulation: effects on umbilical artery resistance.
Topics: Adult; Antihypertensive Agents; Dose-Response Relationship, Drug; Female; Fetus; Humans; Hydralazine; Labetalol; Magnesium Sulfate; Methyldopa; Nifedipine; Placenta; Pre-Eclampsia; Pregnancy; Regional Blood Flow; Umbilical Arteries; Vascular Resistance | 2004 |
Permanent visual deficits secondary to the HELLP syndrome.
Topics: Adult; Blood Pressure; Brain Infarction; Drug Therapy, Combination; Eclampsia; Female; Furosemide; HELLP Syndrome; Hemianopsia; Humans; Intracranial Hemorrhages; Labetalol; Magnetic Resonance Imaging; Mannitol; Nifedipine; Occipital Lobe; Pregnancy; Retinal Hemorrhage; Visual Acuity | 2005 |
The treatment of severe hypertension in pregnancy: a review of current practice and knowledge in West-Midlands maternity units.
Topics: Antihypertensive Agents; Female; Hospital Units; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Obstetrics; Practice Patterns, Physicians'; Pregnancy | 2004 |
Changes in behavior as an early symptom of renovascular hypertension in children.
Topics: Angiography; Antihypertensive Agents; Atenolol; Attention Deficit Disorder with Hyperactivity; Child Behavior Disorders; Child, Preschool; Female; Follow-Up Studies; Humans; Hypertension, Renovascular; Labetalol; Nifedipine; Renal Artery; Retrospective Studies; Time Factors; Treatment Outcome; Vasodilator Agents | 2009 |
False-positive amphetamine toxicology screen results in three pregnant women using labetalol.
Topics: Adult; Amphetamine; Antihypertensive Agents; Cesarean Section; Chronic Disease; Cocaine; Cross Reactions; False Positive Reactions; Female; Gas Chromatography-Mass Spectrometry; Humans; Hypertension, Pregnancy-Induced; Immunoassay; Infant, Newborn; Labetalol; Nifedipine; Pregnancy; Pregnancy Outcome; Pulmonary Edema; Stillbirth; Substance Abuse Detection | 2011 |
Dutch guideline for the management of hypertensive crisis -- 2010 revision.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Emergency Treatment; Humans; Hypertension; Hypertensive Retinopathy; Internal Medicine; Labetalol; Netherlands; Nicardipine; Nifedipine; Nitroprusside; Practice Guidelines as Topic | 2011 |
Nifedipine versus labetalol in the treatment of hypertensive disorders of pregnancy.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Female; Humans; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Pregnancy; Pregnancy Outcome; Retrospective Studies | 2012 |
Multiple cerebral infarctions related to famotidine-induced eosinophilia.
Topics: Acarbose; Adrenergic alpha-1 Receptor Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antihypertensive Agents; Aspirin; Calcium Channel Blockers; Cerebral Infarction; Diabetes Mellitus, Type 2; Diffusion Magnetic Resonance Imaging; Drug-Related Side Effects and Adverse Reactions; Eosinophilia; Famotidine; Humans; Hypertension; Hypoglycemic Agents; Labetalol; Male; Metformin; Middle Aged; Nifedipine; Peptic Ulcer; Prazosin; Sulfonylurea Compounds | 2012 |
Maternal antihypertensive drugs may influence cerebral oxygen extraction in preterm infants during the first days after birth.
Topics: Antihypertensive Agents; Case-Control Studies; Cerebral Cortex; Cerebrovascular Circulation; Female; Humans; Hypertension, Pregnancy-Induced; Infant, Newborn; Infant, Premature; Labetalol; Magnesium Sulfate; Male; Nifedipine; Oxygen Consumption; Pregnancy; Prenatal Exposure Delayed Effects | 2013 |
Oral nifedipine or intravenous labetalol for severe hypertension?
Topics: Antihypertensive Agents; Female; Humans; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications, Cardiovascular | 2016 |
Severe maternal morbidity in a large cohort of women with acute severe intrapartum hypertension.
Topics: Adult; Antihypertensive Agents; California; Female; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Labetalol; Morbidity; Nifedipine; Pregnancy; Retrospective Studies; Young Adult | 2016 |
The Effect of Maternal Antihypertensive Drugs on the Cerebral, Renal and Splanchnic Tissue Oxygen Extraction of Preterm Neonates.
Topics: Antihypertensive Agents; Brain; Cerebrovascular Circulation; Female; Gestational Age; Hemodynamics; Humans; Infant, Newborn; Infant, Premature; Kidney; Labetalol; Magnesium Sulfate; Male; Maternal Exposure; Netherlands; Neuroprotection; Nifedipine; Oxygen Consumption; Pre-Eclampsia; Pregnancy; Spectroscopy, Near-Infrared; Time Factors; Tocolysis | 2016 |
Committee Opinion No. 692 Summary: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period.
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Drug Administration Routes; Emergencies; Female; Humans; Hypertension; Labetalol; Medication Therapy Management; Nifedipine; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Quality Improvement; Referral and Consultation; Severity of Illness Index; United States | 2017 |
Committee Opinion No. 692: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period.
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Drug Administration Routes; Emergencies; Female; Humans; Hypertension; Labetalol; Medication Therapy Management; Nifedipine; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Quality Improvement; Referral and Consultation; Severity of Illness Index; United States | 2017 |
Treating normal early gestation placentae with preeclamptic sera produces extracellular micro and nano vesicles that activate endothelial cells.
Topics: Cells, Cultured; Endothelial Cells; Extracellular Vesicles; Female; HMGB1 Protein; Humans; Immune Sera; Intercellular Adhesion Molecule-1; Labetalol; Nanoparticles; Nifedipine; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, First; Tocolytic Agents; Up-Regulation | 2017 |
A trial of oral nifedipine and oral labetalol in preeclampsia hypertensive emergency treatment.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Drug Administration Schedule; Emergency Treatment; Female; Humans; Labetalol; Nifedipine; Pre-Eclampsia; Pregnancy; Prenatal Care; Retrospective Studies; Time Factors; Treatment Outcome | 2017 |
The effect of labetalol and nifedipine MR on blood pressure in women with chronic hypertension in pregnancy.
Topics: Adrenergic Antagonists; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Chronic Disease; Delayed-Action Preparations; Female; Heart Rate; Humans; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Pregnancy; Time Factors; Treatment Outcome; Vasodilator Agents | 2018 |
Oral short-acting antihypertensive medications and the occurrence of stroke: a nationwide case-crossover study.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Captopril; Cerebral Hemorrhage; Female; Humans; Labetalol; Male; Middle Aged; Nifedipine; Retrospective Studies; Stroke | 2019 |
Oral regimen management of acute hypertension in pregnancy.
Topics: Antihypertensive Agents; Female; Humans; Hypertension; Labetalol; Methyldopa; Nifedipine; Pregnancy; Pregnancy Complications, Cardiovascular | 2019 |
Identification of factors associated with delayed treatment of obstetric hypertensive emergencies.
Topics: Administration, Intravenous; Administration, Oral; Adult; After-Hours Care; Antihypertensive Agents; Black or African American; Chronic Disease; Emergencies; Ethnicity; Female; Gestational Age; Hispanic or Latino; Humans; Hydralazine; Hypertension; Hypertension, Pregnancy-Induced; Labetalol; Labor, Obstetric; Nifedipine; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Retrospective Studies; Risk Factors; Severity of Illness Index; Time-to-Treatment; White People | 2020 |
Regulation of magnesium sulfate combined with nifedipine and labetalol on disease-related molecules in serum and placenta in the treatment of preeclampsia.
Topics: Administration, Oral; Adult; E-Selectin; Female; Humans; Labetalol; Magnesium Sulfate; Nifedipine; Pre-Eclampsia; Pregnancy; Prospective Studies; Transforming Growth Factor beta1; Vascular Cell Adhesion Molecule-1; Young Adult | 2020 |
Semiautonomous Treatment Algorithm for the Management of Severe Hypertension in Pregnancy.
Topics: Adult; Algorithms; Antihypertensive Agents; Female; Humans; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Pregnancy; Retrospective Studies | 2021 |
Preventing Recurrent Preeclampsia by Tailored Treatment of Nonphysiologic Hemodynamic Adjustments to Pregnancy.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Female; Hemodynamics; Humans; Labetalol; Methyldopa; Nifedipine; Pre-Eclampsia; Pregnancy; Secondary Prevention | 2021 |
Which antihypertensive treatment is better for mild to moderate hypertension in pregnancy?
Topics: Antihypertensive Agents; Female; Humans; Hypertension, Pregnancy-Induced; Labetalol; Methyldopa; Nifedipine; Pregnancy; Prenatal Care; Treatment Outcome | 2022 |
Gestational weight gain among gravidae with hypertension receiving labetalol versus nifedipine.
Topics: Antihypertensive Agents; Blood Pressure; Female; Gestational Weight Gain; Humans; Hypertension; Labetalol; Nifedipine; Pre-Eclampsia | 2022 |
Maternal and neonatal outcomes of antihypertensive treatment in pregnancy: A retrospective cohort study.
Topics: Antihypertensive Agents; Birth Weight; Female; Humans; Hypertension, Pregnancy-Induced; Infant; Infant, Newborn; Infant, Newborn, Diseases; Labetalol; Methyldopa; Nifedipine; Pregnancy; Pregnancy Outcome; Premature Birth; Retrospective Studies | 2022 |
Race/ethnicity differences in response to acute antihypertensive treatment of peripartum severe hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Ethnicity; Female; Humans; Hydralazine; Hypertension; Labetalol; Nifedipine; Peripartum Period; Pregnancy; Retrospective Studies | 2022 |
Postpartum Readmission for Hypertension After Discharge on Labetalol or Nifedipine.
Topics: Antihypertensive Agents; Cohort Studies; Female; Humans; Hypertension; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Patient Discharge; Patient Readmission; Postpartum Period; Pregnancy | 2022 |
Hypertensive Conditions: Hypertensive Disorders in Pregnancy.
Topics: Antihypertensive Agents; Female; Humans; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Pre-Eclampsia; Pregnancy | 2022 |
Postpartum medical management of hypertension and risk of readmission for hypertensive complications.
Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Labetalol; Nifedipine; Patient Readmission; Postpartum Period; Retrospective Studies; Treatment Outcome | 2023 |
Critical commentary on labetalol and nifedipine use in postpartum hypertension management.
Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Postpartum Period | 2023 |
Reply to 'Critical commentary on labetalol and nifedipine use in postpartum hypertension management'.
Topics: Antihypertensive Agents; Female; Humans; Hypertension; Labetalol; Nifedipine; Postpartum Period | 2023 |
Comparison of outcomes following intravenous magnesium compared with intravenous labetalol and oral nifedipine in 355 pregnant Han Chinese women with preeclampsia.
Topics: Antihypertensive Agents; Blood Pressure; East Asian People; Female; Humans; Hypertension; Infant, Newborn; Labetalol; Magnesium Sulfate; Nifedipine; Pre-Eclampsia; Pregnancy | 2023 |